Status | Study |
Recruiting |
Study Name: Modifying Genes in Neurofibromatosis 1 Condition: Neurofibromatosis 1 Date: 2012-05-29 Interventions: Other: No intervention No intervention |
Completed |
Study Name: Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2 Condition: Neurofibromatosis Type II Date: 2011-08-17 Interventions: Drug: Everolimus (RAD001) , Afinitor® Everolimus will be provided by Novartis. Everolimus is formul |
Recruiting |
Study Name: Neurofibromatosis Type 1 Patient Registry Condition: Neurofibromatosis Type 1 Date: 2011-08-02 |
Recruiting |
Study Name: Analysis of Peripheral Nerve Sheath Tumors (PNSTs) in Neurofibromatosis Type 1 (NF1) Patients Condition: Neurofibromatosis Type 1 Date: 2010-10-08 |
Active, not recruiting |
Study Name: Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas Condition: Neurofibromatosis Neurofibromas Date: 2010-06-08 Interventions: Drug: Gleevec Gleevec will be dosed orally with a starting dose of 100 mg twice daily for patients with |
Suspended |
Study Name: PTC299 for Treatment of Neurofibromatosis Type 2 Condition: Neurofibromatosis 2 Date: 2009-05-28 Interventions: Drug: PTC299 PTC299 will be administered orally at 100 mg/dose twice per day for up to 1 year or until t |
Active, not recruiting |
Study Name: A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1 Condition: Neurofibromatosis Type 1 Date: 2009-02-23 Interventions: Drug: Lovastatin ™ Lovas |
Completed |
Study Name: Spinal Abnormalities in Neurofibromatosis Type 1 (NF1) Condition: Neurofibromatosis Type 1 Date: 2009-02-12 |
Completed |
Study Name: Clinical Trial of Pirfenidone in Adult Patients With Neurofibromatosis 1 Condition: Neurofibromatosis Date: 2008-09-16 Interventions: Drug: Pirfenidone Capsule 800 mg TID, oral |
Completed |
Study Name: Multi-Center Project: Spinal Abnormalities in Neurofibromatosis Type1 (NF1) Patients Condition: Neurofibromatosis Type 1 Date: 2008-04-24 |